Cargando…
Xuebijing Protects Against Septic Acute Liver Injury Based on Regulation of GSK-3β Pathway
Xuebijing (XBJ), the only drug approved for the sepsis and multiple organ dysfunction, and its protective effects against acute liver injury (ALI) and its mechanism. The aim of this study was to evaluate the protective effect of XBJ on cecal ligation and perforation (CLP)-induced mouse ALI model and...
Autores principales: | Cao, Liping, Li, Zhenghong, Ren, Yi, Wang, Mengmeng, Yang, Zhizhou, Zhang, Wei, Han, Xiaoqin, Yao, Mengya, Sun, Zhaorui, Nie, Shinan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120308/ https://www.ncbi.nlm.nih.gov/pubmed/33995024 http://dx.doi.org/10.3389/fphar.2021.627716 |
Ejemplares similares
-
Arctigenin Suppressed Epithelial-Mesenchymal Transition Through Wnt3a/β-Catenin Pathway in PQ-Induced Pulmonary Fibrosis
por: Gao, Fei, et al.
Publicado: (2020) -
MicroRNA-139-5p improves sepsis-induced lung injury by targeting Rho-kinase1
por: Zhao, Xinmin, et al.
Publicado: (2021) -
Beneficial effect of Xuebijing against Pseudomonas aeruginosa infection in Caenorhabditis elegans
por: Zhang, Le, et al.
Publicado: (2022) -
Interference with connective tissue growth factor attenuated fibroblast-to-myofibroblast transition and pulmonary fibrosis
por: Yang, Zhizhou, et al.
Publicado: (2022) -
Metabolomic Insights Into the Synergistic Effect of Biapenem in Combination With Xuebijing Injection Against Sepsis
por: Liu, Li-Wei, et al.
Publicado: (2020)